Report Categories
View AllRecent Articles
View All
EBS Emergent BioSolutions crushes EPS estimates by 183 but faces revenue headwinds with 30 annual decline shares edge higher
Why 17 YQ ability to innovate sets it apart 142 20260503
The real story behind Lifezone LZM earnings numbers Q2 2024 EPS Misses Views
What Cadre CDRE management focus reveals about priorities 332 20260506
How Soluna Holdings SLNH manages its cash position Q4 2025 EPS Misses Views
ZURA Zura Bio posts far wider Q4 2025 loss than consensus estimates sending its shares down 254 today
InflaRx NV IFRX stock jumps 6 despite 82 revenue decline EPS beats estimates by 2
DCTH Delcath posts narrower than expected Q4 2025 loss stock rises nearly two percent in todays trading
CIFR Cipher Digital shares drop 395 as Q4 2025 EPS misses consensus estimates by a steep 267 percent
BDX BD notches narrow Q1 2026 EPS beat shares drop 175 percent amid soft investor sentiment